Wednesday December 14, 2016 – Vancouver, BC – Regimen Equity Partners has announced their partnership and equity investment in All Gold Imports Inc. This is the fourth platform investment of their inaugural fund.
After announcing a $6 million Series B in September, Toronto-based Chefs Plate announced that it’s closed the second tranche of its Series B thanks to its commitment on food sustainability; the tranche was closed by InvestEco Capital’s Sustainable Food Fund II, which focuses on companies that support food waste reduction and sustainability.
Bayer AG and Versant Ventures are dedicating $295 million ($225 million USD) to launching BlueRock Therapeutics, a stem cell company that will work in collaboration with institutions from Canada, the US, and Japan. BlueRock will have research and development operations in Toronto, New York, and Boston.
Today, Bayer AG and Versant Ventures announced an investment of $225-million US to launch BlueRock Therapeutics, a next-generation regenerative medicine company focused on breakthrough stem cell technology treatments. The announcement marks one of the largest series A financing rounds in history for a biotech company.